Mary Maral Mouradian

Title: Mary Maral Mouradian: Innovator in Neurodegenerative Disease Treatments

Introduction

Mary Maral Mouradian is a prominent inventor based in Princeton, NJ (US). She has made significant contributions to the field of neurodegenerative diseases, particularly through her innovative patents. With a total of 2 patents, her work focuses on developing therapeutic methods to treat conditions such as dyskinesia and other alpha-synucleinopathies.

Latest Patents

Mouradian's latest patents include a method for treating dyskinesia, which involves administering a therapeutically effective amount of a dual-action mu-opioid receptor antagonist/kappa-opioid receptor agonist or a prodrug thereof. This method aims to mitigate dyskinesia in patients. Additionally, she has developed therapies and assays for RNA targeting in alpha-synucleinopathies, which screen for small molecules that can be therapeutically useful in controlling neurodegenerative diseases like Parkinson's.

Career Highlights

Mary Maral Mouradian is affiliated with Rutgers, the State University of New Jersey, where she continues her research and innovation in the field. Her work has garnered attention for its potential impact on treating debilitating conditions that affect millions of individuals.

Collaborations

Mouradian collaborates with esteemed colleagues, including Steven P Braithwaite and Michael Voronkov, to advance her research and develop new therapeutic strategies.

Conclusion

Mary Maral Mouradian stands out as a key figure in the innovation of treatments for neurodegenerative diseases. Her patents reflect her commitment to improving patient outcomes and advancing medical science.